The Principles of Clinical Cytogenetics - Extra Materials - Springer

416 Rizwan Naeem
169. Rosenberg, C.L., Wong, E., Petty, E.M., et al. (1991) PRAD1, a candidate BCL1 oncogene: mapping and expression in
centrocytic lymphoma. Proc. Natl. Acad. Sci. USA 88, 9638–9642.
170. Williams, M.E., Westermann, C.D., and Swerdlow, S.H. (1990) Genotypic characterization of centrocytic lymphoma:
frequent rearrangement of the chromosome 11 bcl-1 locus. Blood 76, 1387–1391.
171. Williams, M.E., Swerdlow, S.H., Rosenberg, C.L., and Arnold, A. (1993) Chromosome 11 translocation breakpoints at
the PRAD1/cyclin D1 gene locus in centrocytic lymphoma. Leukemia 7, 241–245.
172. Li, J.Y., Gaillard, F., Moreau, A., et al. (1999) Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma
by fluorescence in situ hybridization. Am. J. Pathol. 154, 1449–1452.
173. Vaandrager, J.W., Schuuring, E., Zwikstra, E., et al. (1996) Direct visualization of dispersed 11q13 chromosomal translocations
in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization. Blood 88, 1177–1182.
174. de Boer, C.J., van Krieken, J.H., Kluin-Nelemans, H.C., Kluin, P.M., and Schuuring, E. (1995) Cyclin D1 messenger
RNA overexpression as a marker for mantle cell lymphoma. Oncogene 10, 1833–1840.
175. Campo, E., Raffeld, M., and Jaffe, E.S. (1999) Mantle-cell lymphoma. Semin. Hematol. 36, 115–127.
176. Ott, G., Kalla, J., Hanke, A., et al. (1998) The cytomorphological spectrum of mantle cell lymphoma is reflected by
distinct biological features. Leukemia Lymphoma 32, 55–63.
177. Fang, N.Y., Greiner, T.C., Weisenburger, D.D., et al. (2003) Oligonucleotide microarrays demonstrate the highest
frequency of ATM mutations in the mantle cell subtype of lymphoma. Proc. Natl. Acad. Sci. USA 100, 5372–5377.
178. Woroniecka, R., Pienkowska-Grela, B., Grygalewicz, B., et al. (2002) Significance of chromosomal markers in the
diagnosis of mantle cell lymphoma (MCL). J. Appl. Genet. 43, 545–453.
179. Weiss, L.M., Warnke, R.A., Sklar, J., and Cleary, M.L. (1987) Molecular analysis of the t(14;18) chromosomal translocation
in malignant lymphomas. N. Engl. J. Med. 317, 1185–1189.
180. Lipford, E., Wright, J.J., Urba, W., et al. (1987) Refinement of lymphoma cytogenetics by the chromosome 18q21
major breakpoint region. Blood 70, 1816–1823.
181. Yunis, J.J., Mayer, M.G., Arnesen, M.A., Aeppli, D.P., Oken, M.M., and Frizzera, G. (1989) bcl-2 and other genomic
alterations in the prognosis of large-cell lymphoma. N. Engl. J. Med. 320, 1047–1054.
182. Peters, K., Zettl, A., Starostik, P., et al. (2000) Genetic imbalances in primary gastric diffuse large B-cell lymphomas:
comparison of comparative genomic hybridization, microsatellite, and cytogenetic analysis. Diagn. Mol. Pathol. 9, 58–65.
183. Wilson, W.H., Teruya-Feldstein, J., Fest, T., et al. (1997) Relationship of p53, bcl-2, and tumor proliferation to clinical
drug resistance in non-Hodgkin’s lymphomas. Blood 89, 601–609.
184. Offit, K., Lo Coco, F., Louie, D.C., et al. (1994) Rearrangement of the bcl-6 gene as a prognostic marker in diffuse
large-cell lymphoma. N. Engl. J. Med. 331, 74–80.
185. Harris, N.L., Jaffe, E.S., Stein, H., et al. (1994) A revised European–American classification of lymphoid neoplasms:
a proposal from the International Lymphoma Study Group. Blood 84, 1361–1392.
186. Hui, P.K., Feller, A.C., and Lennert, K. (1988) High-grade non-Hodgkin’s lymphoma of B-cell type. I. Histopathology.
Histopathology 12, 127–143.
187. Wright, D.H. (1971) Burkitt’s lymphoma: a review of the pathology, immunology, and possible etiologic factors. Pathol.
Annu. 6, 337–363.
188. Wright, D.H. (1997). What is Burkitt’s lymphoma? J. Pathol. 182, 125–127.
189. Klein, U., Klein, G., Ehlin-Henriksson, B., Rajewsky, K., and Kuppers, R. (1995) Burkitt’s lymphoma is a malignancy
of mature B-cells expressing somatically mutated V region genes. Mol. Med. 1, 495–505.
190. Tamaru, J., Hummel, M., Marafioti, T., et al. (1995) Burkitt’s lymphomas express VH genes with a moderate number
of antigen-selected somatic mutations. Am. J. Pathol. 147, 1398–1407.
191. Gaidano, G., Ballerini, P., Gong, J.Z., et al. (1991) p53 mutations in human lymphoid malignancies: association with
Burkitt lymphoma and chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 88, 5413–5417.
192. Gutierrez, M.I., Bhatia, K., Barriga, F., et al. (1992) Molecular epidemiology of Burkitt’s lymphoma from South
America: differences in breakpoint location and Epstein-Barr virus association from tumors in other world regions.
Blood 79, 3261–3266.
193. Yano, T., Sander, C.A., Clark, H.M., Dolezal, M.V., Jaffe, E.S., and Raffeld, M. (1993) Clustered mutations in the
second exon of the MYC gene in sporadic Burkitt’s lymphoma. Oncogene 8, 2741–2748.
194. Cairo, M.S., Sposto, R., Perkins, S.L., et al. (2003) Burkitt’s and Burkitt-like lymphoma in children and adolescents: a
review of the Children’s Cancer Group experience. Br. J. Haematol. 120, 660–670.
195. Matutes, E., Brito-Babapulle, V., Swansbury, J., et al. (1991) Clinical and laboratory features of 78 cases of
T-prolymphocytic leukemia. Blood 78, 3269–3274.
196. Matutes, E., Crockard, A.D., O’Brien, M., and Catovsky, D. (1983). Ultrastructural cytochemistry of chronic T-cell
leukaemias. A study with four acid hydrolases. Histochem. J. 15, 895–909.
197. Brito-Babapulle, V. and Catovsky, D. (1991) Inversions and tandem translocations involving chromosome 14q11 and
14q32 in T-prolymphocytic leukemia and T-cell leukemias in patients with ataxia telangiectasia. Cancer Genet.
Cytogenet. 55, 1–9.
198. Maljaei, S.H., Brito-Babapulle, V., Hiorns, L.R., and Catovsky, D. (1998) Abnormalities of chromosomes 8, 11, 14,
and X in T-prolymphocytic leukemia studied by fluorescence in situ hybridization. Cancer Genet. Cytogenet. 103,
110–116.